| Cas No.: | 25316-40-9 |
| 名称: | (8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride |
| 别名: | |
| SMILES: | C1=CC2C(=O)C3=C(O)C4C[C@](O)(C(CO)=O)C[C@@H](O[C@H]5O[C@H](C)[C@H](O)[C@H](N)C5)C=4C(O)=C3C(=O)C=2C(OC)=C1.[H]Cl |
| 分子式: | C27H29NO11.HCl |
| 分子量: | 579.98 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Doxorubicin hydrochloride is the hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxor |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
